CA1020460A - Separation du glycopeptide immunostimulant des bacteries - Google Patents

Separation du glycopeptide immunostimulant des bacteries

Info

Publication number
CA1020460A
CA1020460A CA193,265A CA193265A CA1020460A CA 1020460 A CA1020460 A CA 1020460A CA 193265 A CA193265 A CA 193265A CA 1020460 A CA1020460 A CA 1020460A
Authority
CA
Canada
Prior art keywords
bacteria
isolation
immunostimulating
glycopeptide
immunostimulating glycopeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA193,265A
Other languages
English (en)
Other versions
CA193265S (en
Inventor
Christopher Adlam
David E. Reid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB914973A external-priority patent/GB1476422A/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of CA1020460A publication Critical patent/CA1020460A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA193,265A 1973-02-23 1974-02-22 Separation du glycopeptide immunostimulant des bacteries Expired CA1020460A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB914973A GB1476422A (en) 1973-02-23 1973-02-23 Biological extracts
GB675974 1974-02-14

Publications (1)

Publication Number Publication Date
CA1020460A true CA1020460A (fr) 1977-11-08

Family

ID=26240935

Family Applications (1)

Application Number Title Priority Date Filing Date
CA193,265A Expired CA1020460A (fr) 1973-02-23 1974-02-22 Separation du glycopeptide immunostimulant des bacteries

Country Status (3)

Country Link
US (1) US4010257A (fr)
CA (1) CA1020460A (fr)
CH (1) CH602920A5 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2374042A1 (fr) * 1976-06-04 1978-07-13 Merieux Inst Nouveau medicament immunostimulant et son procede de preparation
FR2460139A1 (fr) * 1979-06-29 1981-01-23 Pasteur Institut Fraction antigenique glycopeptidique vaccinante a tres grande immunogenicite isolee de cultures de germes pathogenes, procedes d'isolement de cette fraction et vaccins contenant ladite fraction
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
US4520019A (en) * 1982-04-29 1985-05-28 Ribi Immunochem Research, Inc. Stable composition and preparation thereof
US4877612A (en) * 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
DK0681479T3 (da) * 1993-01-29 1999-11-08 Vetrepharm Inc Immunterapeutisk præparat
IL134371A0 (en) 1997-08-05 2001-04-30 Bioniche Life Sciences Inc Composition and method for regulating cell proliferation and cell death
MXPA02005842A (es) * 1999-12-13 2003-10-14 Bioniche Life Sciences Inc Oligonucleotidos sinteticos terapeuticamente utiles.
WO2001047561A1 (fr) * 1999-12-28 2001-07-05 Bioniche Life Sciences Inc. L'acide hyaluronique dans le traitement du cancer
AU2001251316A1 (en) * 2000-04-04 2001-10-15 Antigenics Inc. Isolated and purified nonpeptide antigens from mycobacterium tuberculosis

Also Published As

Publication number Publication date
US4010257A (en) 1977-03-01
CH602920A5 (fr) 1978-08-15

Similar Documents

Publication Publication Date Title
CA986735A (en) Duct wall acoustic treatment
CA997742A (en) Anti-contaminant diaphragm valve
NZ174950A (en) Antibiotic fortimicin a from the culture of micromonosporaolivo asterospora
CA1033860A (fr) Separation des caoutchoucs
CA1014412A (en) Fermentation of soya
CA1020460A (fr) Separation du glycopeptide immunostimulant des bacteries
CA1035792A (fr) Sec-5 alhyl-m-cresol
CA1019800A (en) Translating dwell cleaning system
AU474307B2 (en) Vacuum reducer valve
CA1019365A (en) Self-locking coupling for pipes
ZA741801B (en) Process for isolation of antibiotic av290
CA1014974A (en) Process for the preparation of 5-chloro-2-toluidine
CA1036169A (fr) Mode de fabrication de poly-n-alkyliminoalanes
CA1002473A (en) Pipeline milking system
CA995608A (en) Anthracyclic antibiotic from actinomandura carminata
CA1025357A (fr) Isolation d'anticoagulants
NO139864C (no) B fremgangsmaate til fremstilling av antibiotikum fortimicin
CA1026326A (fr) PROCEDE DE SYNTHESE DES .alpha.-6-DESOXYTETRACYCLINES
CA975756A (en) Procede de preparation des derives 21-methyles du pregnane
CA1004655A (en) Preparation of zeolites
CA1019347A (en) Process for the preparation of propargylamine
CA1022867A (en) Microbiological process for the preparation of oxoalkylxanthines
CA1034497A (fr) Procede de preparation du choleragene
CH612996A5 (en) Process for the preparation of the antibiotic FR-02A
CA962372A (en) Isolation of semiconductor devices